Plasma D-Dimer as a Marker for Postoperative Deep Venous Thrombosis- A Study after Total Hip or Knee Arthroplasty

Thromb Haemost 1995; 73(04): 728
DOI: 10.1055/s-0038-1653851

Letters to the Editor

Schattauer GmbH Stuttgart

Paul D Triffitt

Department of Orthopaedic Surgery, University of Leicester, Leicester, UK

References
1 Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. N Engl J Med 1988; 318: 1162-1173
2 Colwell CW, Spiro TE, Trowbridge AA, Morris BA, Kwaan HC, Blaha JD, Comerota AJ, Skoutakis VA. Use of Enoxaparin a low-molecular-weight heparin and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. J Bone Joint Surg (Am) 1994; 76: 3-14
3 Francis CW, Ricotta JJ, Evarts CM, Marder VJ. Long-term clinical observations and venous functional abnormalities after asymptomatic venous thrombosis following total hip or knee arthroplasty. Clin Orthop 1988; 232: 271-278
4 Gent M, Roberts RS. A meta-analysis of the studies of dihydroergotamine plus heparin in the prophylaxis of deep vein thrombosis. Chest 1986; 89: 396-400
5 Murray DW, Carr AJ, Bulstrode CJ K. Pharmacological prophylaxis and total hip replacement. J Bone Joint Surg [Br] 1995; 77-B: 3-5
6 Trowbridge A, Boese CK, Woodruff B, Brindley Sr HH, Lowry WE, Spiro TE. Incidence of posthospitalization proximal deep venous thrombosis after total hip arthroplasty. A pilot study Clin Orthop 1994; 299: 203-208
7 Warwick D, Williams MH, Bannister G C. Death and thromboembolic disease after total hip replacement. J Bone Joint Surg [Br] 1995; 77-B: 6-10